(“Ananda” or the “Company”)
Result of General Meeting
The Company is pleased to announce that at the General Meeting held earlier today, the resolution put to shareholders was duly passed.
As a result, the Company has completed its purchase of 15 per cent. of
The directors of the Company accept responsibility for the contents of this announcement.
Ananda Developments plc+44 (0)739 269 6517 Executive Director Melissa SturgessInvestor Relations firstname.lastname@example.org Jeremy Sturgess-Smith Peterhouse Capital Limited+44 (0)20 7469 0930 Corporate Finance Fungai Ndoro Mark AnwylCorporate Broker Lucy Williams Duncan Vasey Celicourt Communications+44 (0)20 7520 9261 Mark Atelme Joanna Boon
Notes to editors
Ananda Developments has been established as a company to invest in the developing market for medical or therapeutic Cannabis derivatives, or related products, including but not limited to nutraceuticals, dietary supplements and cosmetic products which contain Cannabis or hemp derived cannabinoids. The Directors believe that this market is growing due to an increasing number of states in the
Ananda’s investment strategy is to invest in companies, projects or products that are either progressing medical or therapeutic Cannabis research and development, or are developing or have already developed, products that contain Cannabis derived cannabinoids and require funding to progress work plans or commercialise products.